Cannathemag
  • News
  • Magazine
  • Advertising
  • About Us
  • Language Services
  • Contacts
  • Search
  • CZCZ
Facebook Instagram

Large Pharmaceutical Group Takes over Reins of Cannabis Medicine

17. March 2021 | Category: News
Source: pixabay.com

Source: pixabay.com

At the beginning of February, representatives of the Jazz Pharmaceuticals Plc announced the acquisition of the GW Pharmaceuticals Plc for $7.2 billion in cash and stock.

GW, based in Cambridge, England, is currently the only real “cannabis-pharmaceutical” company in the world that develops approved drugs derived from the cannabis plant. Jazz Pharma is a giant in the market for conventional pharmaceuticals, with focus on neurological and oncological diseases.

Deal-making is in full-swing again in the cannabis industry.

Both cannabinoid preparations produced by GW are designed for patients with neurological problems – Sativex (based on THC/CBD) is used for the treatment of multiple sclerosis, while Epidiolex (based on CBD) is used for children with severe epilepsy.

Deal-making is in full-swing again in the cannabis industry: in December, two of the biggest players, Tilray Inc. and Aphria Inc., agreed to combine in a deal valued at $3.8 billion.

Author: Bob Hýsek

Source: Cannabis Therapy Vol. 2

Take a quick look at this preview of the contents:

Feel free to read, share and download here. Enjoy!

Ohodnoťte tento článek
cannabis industrycannabis marketCBDepidiolexneurological diseasesOncological diseasespharmaceuticalsSativexTHC

You might like

  • Source: Unsplash.com News

    Argentina allows patients to grow their own cannabis

  • Source: Pexels.com News

    Cannabis job growth exceeds any other industry in the U.S.

  • News

    Shifts in the Attitudes Towards Cannabis Are Felt Throughout the World

Write comment Cancel

Search

Latest News

  • Hana Gabrielová is inviting you to upcoming conference Hemp & Industry in Prague

    24. September 2023
  • Source: Hagit Yagoda

    Activism: Fighting Cancer and Prejudices

    19. September 2023
  • Don’t miss the unique Hemp & Industry conference!

    13. September 2023
  • hemp field in Poland

    Argentinian Hemp Delegation Visits Poland and Czechia

    8. August 2023
Facebook YouTube SoundCloud
  • Advertising
  • Magazine
  • About Us
  • Contacts
  • Terms and Conditions

CANNABIS THERAPY

Magazine about medical uses of cannabis. For patients, health professionals as well as general public. Free of charge.

Contact: office@konomag.cz

Tel.: +420 737 300 375

CATEGORIES

  • Advice
  • Breaking News
  • Health
  • Inspiration
  • Interviews
  • Leaves of Grass
  • News
  • Pharmacopeia
  • Pharmacopoeia
  • Press Release
  • Research Reports
  • Uncategorized
  • Veterinary Medicine

LATEST NEWS

  • Hana Gabrielová is inviting you to upcoming conference Hemp & Industry in Prague

    24. September 2023
  • Source: Hagit Yagoda

    Activism: Fighting Cancer and Prejudices

    19. September 2023

SEARCH

Follow us

Facebook Instagram
  • © 2018-23 CANNABIS THERAPY magazine. All rights belong to their respective owners. Without their written consent it is prohibited to use parts or whole works in any way, particularly spreading and copying, mechanically or electronically, in English, Czech or any other language.

  • Cannathemag

    Manage consent to cookies
    We use technologies such as cookies to store and/or access device information. We do this to improve your browsing experience and display personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or a unique ID on this website. Disagreeing or withdrawing consent may adversely affect certain features and functions.
    Functional Always active
    Technical storage or access is absolutely necessary for the legitimate purpose of enabling the use of a specific service that the subscriber or user has expressly requested, or for the sole purpose of carrying out the transmission of a message via an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    Technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    Technical storage or access is necessary to create user profiles in order to send advertising or track the user across a website or several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    Show preferences
    {title} {title} {title}
    Are you 18+?

    This website requires you to be of legal age. By clicking Yes, you verify you are at least 18 years old.